Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's What Investors Should Know About Johnson & Johnson's FDA Authorization

TheMotleyFool

0 0

Here's What Investors Should Know About Johnson & Johnson's FDA Authorization

In this video from Motley Fool Live, recorded on March 1, Fool.com Contributors Brian Orelli and Keith Speights discuss the FDA's emergency use authorization (EUA) for Johnson & Johnson's (NYSE: JNJ) coronavirus vaccine. The duo talk about the advisory committee meeting that reviewed the merits of the authorization, as well as the lack of information on the vaccine's use in older adults.

Source Fool.com

Like: 0

JNJ

Share